Skip to main content
Cenra Inc. logo

Cenra Inc. — Investor Relations & Filings

Ticker · 3716 ISIN · TW0003716007 TW Manufacturing
Open in API
Filings indexed 399 across all filing types
Latest filing 2024-09-13 Investor Presentation
Country TW Taiwan
Listing TW 3716

About Cenra Inc.

https://www.cenra.com/

Cenra Inc. is a diversified healthcare enterprise with a history dating back to 1952. The company operates across a comprehensive value chain encompassing research and development, manufacturing, commercial marketing, and long-term care services. Its extensive portfolio includes active pharmaceutical ingredients (APIs), human pharmaceuticals, animal health products, and consumer health brands such as dietary supplements and personal care items. With a global reach spanning over 60 markets, the organization utilizes nine production bases and more than ten specialized technology platforms to deliver integrated health solutions. Cenra Inc. focuses on high-barrier oncology medications, complex generics, and 505(b)(2) drug developments. By integrating scientific innovation with rigorous operational management, the company provides accessible medical care and health services designed to meet evolving needs across all life stages.

Recent filings

Filing Released Lang Actions
113年09月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing from a public information observation station showing details about a company's investor conference call or presentation, including date, time, location, summary, and links to presentation materials and video. The content focuses on a '法人說明會' which translates to 'investor presentation' or 'analyst meeting'. There is no detailed financial report or earnings data, only references to presentation materials and a video link. The document length is short (774 characters), and it serves as an announcement or summary of an investor presentation event rather than the full report itself. Therefore, the most appropriate classification is 'Investor Presentation (IP)'.
2024-09-13 Chinese
公告本公司受邀參加富邦證券舉辦之線上法人說明會
Regulatory Filings Classification · 95% confidence The document is a short announcement (645 characters) about the company 3716 中化控股 being invited to participate in an online investor presentation hosted by 富邦證券. It includes details such as date, time, and content summary of the presentation (company operations and future outlook). There is no detailed financial data or full transcript, only an announcement of the event. According to the 'MENU VS MEAL' rule, this is an announcement of an investor presentation, not the presentation itself. Therefore, the correct classification is Investor Presentation (IP). However, since the document only announces the event and does not contain the presentation content, it fits best as a Regulatory Filing (RNS) or Report Publication Announcement (RPA). But RPA is for announcements about report publication, not event invitations. Hence, the best fit is Regulatory Filings (RNS) as a general announcement of the event.
2024-09-12 Chinese
公告本公司董事會決議召開113年度第1次股東臨時會 相關事宜
Board/Management Information Classification · 95% confidence The document is a formal announcement from the company 3716 中化控股 regarding the board resolution to convene the 113th year first extraordinary shareholders meeting. It includes details such as the date of the meeting, location, meeting format, agenda items including board director re-election and lifting of non-compete restrictions. There are no financial statements or detailed financial data presented. The document is an announcement about a shareholders meeting and board decisions, not a full report or financial disclosure. It fits best under Board/Management Information (MANG) as it relates to board resolutions and management matters.
2024-09-10 Chinese
113年8月營業收入
Regulatory Filings Classification · 95% confidence The document is very short (565 characters) and consists mainly of a summary table listing company codes and names, with a note about monthly revenue reporting by subsidiaries. There is no detailed financial data, no mention of a specific report, no regulatory certification, or any announcement of voting results or management changes. The content appears to be a general regulatory or informational filing without substantive financial or corporate event details. Therefore, it fits best under the fallback category of Regulatory Filings (RNS).
2024-09-10 Chinese
113年8月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company (中化控股) providing detailed data on fund loans and endorsement guarantees for the current and previous month, including amounts and limits. It contains specific financial figures but is very short (626 characters) and appears to be a regulatory disclosure of financial status rather than a full financial report. It does not present comprehensive financial statements or management discussion, nor does it announce a report publication. The content fits best with a Regulatory Filing (RNS) as it is a general regulatory announcement of financial data without the depth of an interim or annual report.
2024-09-10 Chinese
113年9月2日內部人設質解質
Director's Dealing Classification · 100% confidence The document contains a table listing share pledge changes by a director (董事本人) of the company 中化控股, including details such as pledge dates, pledged shares, and pledgees. This is a report of personal share transactions or dealings by company directors. The document length is short and focused on insider share pledging activity, which fits the definition of Director's Dealing filings.
2024-09-05 Chinese

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.